Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Understand what constitutes the cheapest index fund and how expense ratios affect long-term growth. Compare options to choose wisely.
12,952 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
As investors digest Organogenesis (Orgo) 2025 earnings, the focus shifts to revenue mix, profitability, and upcoming ...
Singapore's ComfortDelGro is weighing robotaxi deployments in London as it reports record 2025 revenue, underscoring ...
A Knoxville hospital will be renamed in Dolly Parton’s honor as her philanthropy inspires new literacy efforts at hom...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
Urban air mobility is moving from concept to capital-intensive reality. This article breaks down the battle royale: j...
A strong pharma dividend stock could be a powerful component of a retirement plan. Learn how to choose, invest, and c...
Oil prices jumped after fresh regional strikes disrupted Gulf supply routes, triggering a broader market rally in ene...
Prediction-market odds now place bitcoin's year-end odds reaching 10%. This article breaks down what that means for y...
First Solar has been delivering profits, but a heavy reliance on subsidies creates real investment risk. This article...
JPMorgan’s Jamie Dimon reveals a simple, enduring rule that shaped his ascent from a young Harvard MBA assistant to t...
Klarna has faced a sharp pullback this year, leaving investors wondering if the drop creates a buying opportunity. Th...